共 50 条
Chronotherapy of hypertension: Administration-time-dependent effects of treatment on the circadian pattern of blood pressure
被引:109
|作者:
Hermida, Ramon C.
Ayala, Diana E.
Calvo, Carlos
Portaluppi, Francesco
Smolensky, Michael H.
机构:
[1] Univ Vigo, ETSI Telecommun, Bioengn & Chronobiol Labs, Vigo 36200, Pontevedra, Spain
[2] Hosp Clin Univ, Hypertens & Vasc Risk Unit, Santiago De Compostela 15706, Spain
[3] Univ Ferrara, Dept Clin & Expt Med, Hypertens Ctr, I-44100 Ferrara, Italy
[4] Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Houston, TX 77030 USA
关键词:
Chronotherapy;
chronopharmacodynamics;
antihypertensive therapy;
hypertension;
dipper;
non-dipper;
blood pressure;
circadian variation;
D O I:
10.1016/j.addr.2006.09.021
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Some specific features of the 24-hour blood pressure (BP) pattern are linked to the progressive injury of target tissues and the triggering of cardiac and cerebrovascular events. Thus, there is growing interest in how to best tailor the treatment of hypertensive patients according to the circadian BP pattern of each individual. Significant administration-time differences in the kinetics (i.e., chronokinetics) plus beneficial and adverse effects (i.e., chronodynamics) of antihypertensive medications are well known. Thus, bedtime dosing with nifedipine GITS is more effective than morning dosing, while also significantly reducing adverse effects. The dose-response curve, therapeutic coverage, and efficacy of doxazosin GITS are all markedly dependent on the circadian time of drug administration. Moreover, valsartan administration at bedtime, as opposed to upon wakening, results in an improved diurnal/noctumal BP ratio, increased percentage of controlled patients, and significant reduction in urinary albumin excretion in hypertensive patients. Chronotherapy provides a means of individualizing the treatment of hypertension according to the circadian BP profile of each patient, and constitutes a new option to optimize BP control and to reduce the risk of cardiovascular disease (myocardial infarction and stroke) and of end-organ injury of the blood vessels and tissue of the heart, brain, kidney, eye, and other organs. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:923 / 939
页数:17
相关论文